Open AccessEffect of Anti-IL5, Anti-IL5R, Anti-IL13 Therapy on Asthma Exacerbations: A Network Meta-analysis
Author(s) -
Richard P. Ramonell,
Imran H. Iftikhar
Publication year - 2020
Publication title -
lung
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 57
eISSN - 1432-1750
pISSN - 0341-2040
DOI - 10.1007/s00408-019-00310-8
Subject(s) - mepolizumab , benralizumab , medicine , asthma , dupilumab , exacerbation , meta analysis , placebo , population , immunology , eosinophil , pathology , alternative medicine , environmental health
Several new treatments for severe asthma have become available in the last decade; yet, little data exist to guide their use in specific patient populations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom